Trump Administration in Talks to Offer Low-Dose Obesity Drugs at $149 via TrumpRx

Eli Lilly and Novo Nordisk may provide lowest-dose weight-loss medications through TrumpRx for $149 per month under proposed agreement.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • TrumpRx: A proposed drug distribution program associated with former U.S. President Donald Trump, aiming to offer certain medications at set monthly prices.
  • Obesity drugs: Medications designed to aid weight loss by influencing appetite, metabolism, or nutrient absorption.
  • Eli Lilly: A major U.S.-based pharmaceutical company producing medications across various therapeutic areas, including weight-loss treatments.